World's Best Scientists 2026 revealed!
Charlotte K.Y. Ng

Charlotte K.Y. Ng

D-Index & Metrics

Genetics

D-Index
64
Citations
14651
World Ranking
2794
National Ranking
50

Charlotte K.Y. Ng publication distribution in Genetics in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Genetics in 2026. The highlighted bar marks where Charlotte K.Y. Ng sits on this spectrum.

45–54 publications: 6 scientists 55–64 publications: 10 scientists 65–74 publications: 35 scientists 75–84 publications: 84 scientists 85–94 publications: 102 scientists 95–104 publications: 151 scientists 105–114 publications: 175 scientists 115–124 publications: 203 scientists 125–134 publications: 217 scientists 135–144 publications: 205 scientists 145–154 publications: 193 scientists 155–164 publications: 188 scientists 165–174 publications: 170 scientists 175–184 publications: 178 scientists 185–194 publications: 164 scientists 195–204 publications: 173 scientists 205–214 publications: 159 scientists 215–224 publications: 134 scientists 225–234 publications: 143 scientists 235–244 publications: 105 scientists 245–254 publications: 114 scientists 255–264 publications: 92 scientists 265–274 publications: 88 scientists 275–284 publications: 87 scientists 285–294 publications: 80 scientists 295–304 publications: 62 scientists 305–314 publications: 75 scientists 315–324 publications: 67 scientists 325–334 publications: 60 scientists 335–344 publications: 52 scientists 345–354 publications: 40 scientists 355–364 publications: 48 scientists 365–374 publications: 47 scientists 375–384 publications: 46 scientists 385–394 publications: 31 scientists 395–404 publications: 27 scientists 405–414 publications: 40 scientists 415–424 publications: 30 scientists 425–434 publications: 43 scientists 435–444 publications: 29 scientists 445–454 publications: 14 scientists 455–464 publications: 28 scientists 465–474 publications: 21 scientists 475–484 publications: 21 scientists 485–494 publications: 22 scientists 495–504 publications: 17 scientists 505–514 publications: 12 scientists 515–524 publications: 11 scientists 525–534 publications: 8 scientists 535–544 publications: 8 scientists 545–554 publications: 14 scientists 555–564 publications: 4 scientists 565–574 publications: 11 scientists 575–584 publications: 5 scientists 585–594 publications: 11 scientists 595–604 publications: 12 scientists 605–614 publications: 7 scientists 615–624 publications: 6 scientists 625–634 publications: 10 scientists 635–644 publications: 9 scientists 645–654 publications: 10 scientists 655–664 publications: 6 scientists 665–674 publications: 6 scientists 675–684 publications: 6 scientists 685–694 publications: 4 scientists 695–702 publications: 6 scientists 703+ publications: 100 scientists
45 publications 703+

This scientist: 180 publications — 43rd percentile

43% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 703 publications or more.

Charlotte K.Y. Ng D-index placement in Genetics in 2026

The chart shows the D-index (discipline H-index) distribution of Genetics scientists ranked by Research.com in 2026. The highlighted bar marks where Charlotte K.Y. Ng sits on this spectrum.

40–41 D-Index: 24 scientists 42–43 D-Index: 52 scientists 44–45 D-Index: 84 scientists 46–47 D-Index: 112 scientists 48–49 D-Index: 118 scientists 50–51 D-Index: 141 scientists 52–53 D-Index: 143 scientists 54–55 D-Index: 145 scientists 56–57 D-Index: 179 scientists 58–59 D-Index: 162 scientists 60–61 D-Index: 175 scientists 62–63 D-Index: 191 scientists 64–65 D-Index: 172 scientists 66–67 D-Index: 184 scientists 68–69 D-Index: 164 scientists 70–71 D-Index: 158 scientists 72–73 D-Index: 150 scientists 74–75 D-Index: 136 scientists 76–77 D-Index: 127 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 111 scientists 82–83 D-Index: 110 scientists 84–85 D-Index: 110 scientists 86–87 D-Index: 84 scientists 88–89 D-Index: 102 scientists 90–91 D-Index: 66 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 70 scientists 96–97 D-Index: 54 scientists 98–99 D-Index: 60 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 55 scientists 104–105 D-Index: 45 scientists 106–107 D-Index: 42 scientists 108–109 D-Index: 28 scientists 110–111 D-Index: 39 scientists 112–113 D-Index: 25 scientists 114–115 D-Index: 31 scientists 116–117 D-Index: 29 scientists 118–119 D-Index: 34 scientists 120–121 D-Index: 29 scientists 122–123 D-Index: 29 scientists 124–125 D-Index: 18 scientists 126–127 D-Index: 27 scientists 128–129 D-Index: 22 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 11 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 12 scientists 138–139 D-Index: 21 scientists 140–141 D-Index: 4 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 14 scientists 146–147 D-Index: 6 scientists 148–149 D-Index: 10 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 9 scientists 154–155 D-Index: 8 scientists 156–157 D-Index: 8 scientists 158–159 D-Index: 9 scientists 160+ D-Index: 96 scientists
40 D-Index 160+

This scientist: 64 D-Index — 37th percentile

37% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 160 D-Index or more.

Overview

Charlotte K.Y. Ng is affiliated with Humanitas University in Italy and has contributed extensively to the fields of biochemistry, genetics, molecular biology, and medicine. Their research spans several subfields, prominently including molecular biology, cancer research, pulmonary and respiratory medicine, oncology, and genetics.

Their scientific work focuses on a range of topics related to cancer and molecular mechanisms. These include:

  • Cancer Genomics and Diagnostics
  • Prostate Cancer Treatment and Research
  • Cancer-related Molecular Mechanisms Research
  • RNA Modifications and Cancer
  • Immunotherapy and Immune Responses
  • Ubiquitin and Proteasome Pathways
  • Cancer Immunotherapy and Biomarkers

Charlotte K.Y. Ng has published in a variety of well-regarded venues. Frequent publication outlets include:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Nature Communications
  • Cancer Research
  • Frontiers in Oncology
  • Annals of Oncology

Some of their recent papers are:

  • Integrative proteogenomic characterization of hepatocellular carcinoma across etiologies and stages, 2022, Nature Communications
  • Patient-derived xenografts and organoids model therapy response in prostate cancer, 2021, Nature Communications
  • The Tumor Profiler Study: integrated, multi-omic, functional tumor profiling for clinical decision support, 2021, Cancer Cell
  • Neoantigen prediction and computational perspectives towards clinical benefit: recommendations from the ESMO Precision Medicine Working Group, 2020, Annals of Oncology
  • High Expression of FAP in Colorectal Cancer Is Associated With Angiogenesis and Immunoregulation Processes, 2020, Frontiers in Oncology

The scientist collaborates frequently with several researchers, including:

  • Salvatore Piscuoglio
  • Luigi Terracciano
  • Niko Beerenwinkel
  • Mairene Coto-Llerena
  • Mark A. Rubin

Best Publications

  • Mutation Tracking in Circulating Tumor DNA Predicts Relapse in Early Breast Cancer

    Isaac Garcia-Murillas;Gaia Schiavon;Gaia Schiavon;Britta Weigelt;Charlotte Ng

  • Cerebrospinal fluid-derived circulating tumour DNA better represents the genomic alterations of brain tumours than plasma

    Leticia De Mattos-Arruda;Leticia De Mattos-Arruda;Leticia De Mattos-Arruda;Regina Mayor;Charlotte K. Y. Ng;Britta Weigelt

  • A framework to rank genomic alterations as targets for cancer precision medicine: the ESMO Scale for Clinical Actionability of molecular Targets (ESCAT)

    J. Mateo;D. Chakravarty;R. Dienstmann;S. Jezdic

  • Genomic characterization of metastatic breast cancers

    François Bertucci;Charlotte K. Y. Ng;Charlotte K. Y. Ng;Charlotte K. Y. Ng;Anne Patsouris;Nathalie Droin;Nathalie Droin;Nathalie Droin

  • Spatial and temporal heterogeneity in high-grade serous ovarian cancer: a phylogenetic analysis.

    Roland F. Schwarz;Charlotte K. Y. Ng;Susanna L. Cooke;Scott Newman

  • Capturing intra-tumor genetic heterogeneity by de novo mutation profiling of circulating cell-free tumor DNA: a proof-of-principle

    L. De Mattos-Arruda;L. De Mattos-Arruda;L. De Mattos-Arruda;B. Weigelt;J. Cortes;H.H. Won

  • Breast cancer intra-tumor heterogeneity.

    Luciano G Martelotto;Charlotte K Y Ng;Salvatore Piscuoglio;Britta Weigelt

  • Organoid Models of Human Liver Cancers Derived from Tumor Needle Biopsies

    Sandro Nuciforo;Isabel Fofana;Matthias S. Matter;Tanja Blumer

  • Progression from ductal carcinoma in situ to invasive breast cancer: Revisited

    Catherine F. Cowell;Britta Weigelt;Rita A. Sakr;Charlotte K.Y. Ng

  • Chromosomal instability determines taxane response

    Charles Swanton;Barbara Nicke;Marion Schuett;Aron C. Eklund

  • Diverse BRCA1 and BRCA2 Reversion Mutations in Circulating Cell-Free DNA of Therapy-Resistant Breast or Ovarian Cancer

    Britta Weigelt;Iñaki Comino-Méndez;Ino de Bruijn;Lei Tian

  • Hotspot activating PRKD1 somatic mutations in polymorphous low-grade adenocarcinomas of the salivary glands

    Ilan Weinreb;Salvatore Piscuoglio;Luciano G. Martelotto;Daryl Waggott

  • SF3B1 mutations constitute a novel therapeutic target in breast cancer

    Sarah L. Maguire;Andri Leonidou;Patty Wai;Caterina Marchiò;Caterina Marchiò

  • Massively Parallel Sequencing-Based Clonality Analysis of Synchronous Endometrioid Endometrial and Ovarian Carcinomas.

    Anne M. Schultheis;Charlotte K. Y. Ng;Maria R. De Filippo;Salvatore Piscuoglio

  • The protein histidine phosphatase LHPP is a tumour suppressor

    Sravanth K. Hindupur;Marco Colombi;Stephen R. Fuhs;Matthias S. Matter

  • Genomic analysis of genetic heterogeneity and evolution in high-grade serous ovarian carcinoma

    Susanna L Cooke;Charlotte Ky Ng;Nataliya Melnyk;Maria J Garcia

  • A recurrent neomorphic mutation in MYOD1 defines a clinically aggressive subset of embryonal rhabdomyosarcoma associated with PI3K-AKT pathway mutations.

    Shinji Kohsaka;Neerav Shukla;Nabahet Ameur;Tatsuo Ito

  • The Genomic Landscape of Male Breast Cancers

    Salvatore Piscuoglio;Charlotte K Y Ng;Melissa P. Murray;Elena Guerini-Rocco

  • Benchmarking mutation effect prediction algorithms using functionally validated cancer-related missense mutations

    Luciano G. Martelotto;Charlotte K.Y Ng;Maria R. De Filippo;Yan Zhang

  • The Landscape of Somatic Genetic Alterations in Metaplastic Breast Carcinomas

    Charlotte K.Y. Ng;Charlotte K.Y. Ng;Salvatore Piscuoglio;Salvatore Piscuoglio;Felipe C. Geyer;Kathleen A. Burke

Frequent Co-Authors

Salvatore Piscuoglio
Salvatore Piscuoglio Humanitas University
Jorge S. Reis-Filho
Jorge S. Reis-Filho Memorial Sloan Kettering Cancer Center
Luigi Terracciano
Luigi Terracciano University Hospital of Basel
Larry Norton
Larry Norton Memorial Sloan Kettering Cancer Center
Anne Vincent-Salomon
Anne Vincent-Salomon Institute Curie
Joan Seoane
Joan Seoane Institució Catalana de Recerca i Estudis Avançats
Markus H. Heim
Markus H. Heim University Hospital of Basel
Rachael Natrajan
Rachael Natrajan Institute of Cancer Research
James D. Brenton
James D. Brenton University of Cambridge

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Genetics in the USA opens doors to a range of related online degrees and flexible learning options, ideal for students seeking career-ready qualifications. For those interested in healthcare administration, best medical billing and coding schools online offer specialized programs that can lead to rewarding roles in the medical field.

If speed is a priority, colleges with accelerated programs help you earn your qualification faster, enabling an earlier start to your professional journey. Meanwhile, students who prefer to study at their own pace will benefit from self paced degree programs—ideal for balancing education with work or family commitments.

Additionally, many universities now offer the chance to enroll without up-front costs by choosing from online colleges with no application fee. These diverse educational pathways make it easier than ever to pursue Genetics and related fields, whether your interest is in research, healthcare support, or administration.

Best Scientists Citing Charlotte K.Y. Ng

Trending Scientists

Recently Published Articles